Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases

This study has been completed.
Sponsor:
Information provided by:
Eskisehir Osmangazi University
ClinicalTrials.gov Identifier:
NCT01091402
First received: March 23, 2010
Last updated: NA
Last verified: January 2009
History: No changes posted
  Purpose

One of the proposed mechanisms in CU is autoimmunity. It was shown by a positive response to autologous serum skin test (ASST)in almost half of chronic urticaria (CU) patients. IL-18 also play a role in autoimmune disorders. The investigators aim was to investigate the relationship of ASST and IL-18 in CU and respiratory allergic diseases.


Condition Intervention
Urticaria
Respiratory Allergic Diseases
Procedure: autologous serum skin test, serum IL-18

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Eskisehir Osmangazi University:

Study Start Date: January 2009
Groups/Cohorts Assigned Interventions
chronic urticaria Procedure: autologous serum skin test, serum IL-18
asthma Procedure: autologous serum skin test, serum IL-18
seasonal allergic rhinitis Procedure: autologous serum skin test, serum IL-18
normal controls Procedure: autologous serum skin test, serum IL-18

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

patients from Outpatient clinic

Criteria

Inclusion Criteria:

  • adult patients
  • chronic urticaria patients
  • stable asthma patients
  • allergic rhinitis patients with sensitized to pollens
  • normal controls without atopic and skin disease.

Exclusion Criteria:

  • unwillingness to the study
  • other dermatological problems that could affect the skin test
  • use of antihistamine drugs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01091402

Locations
Turkey
Eskisehir Osmangazi University
Eskisehir, Turkey, 26040
Sponsors and Collaborators
Eskisehir Osmangazi University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01091402     History of Changes
Other Study ID Numbers: 1
Study First Received: March 23, 2010
Last Updated: March 23, 2010
Health Authority: Turkey: Ethics Committee

Keywords provided by Eskisehir Osmangazi University:
autologous serum skin test, IL-18

Additional relevant MeSH terms:
Urticaria
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular

ClinicalTrials.gov processed this record on October 23, 2014